Primary progressive multiple sclerosis treatment market to reach $2.18 billion by 2030 at 13.5% cagr, driven by growing demand for effective treatments for chronic & complex neurological conditions.
Read More
Primary myelofibrosis market to reach $1.14 billion by 2030 at 6.2% cagr, driven by increasing prevalence of myelofibrosis due to aging populations.
Read More
Primary cell culture market to reach $14.54 billion by 2030 at 13.1% cagr, driven by increasing prevalence of chronic diseases and rising demand for advanced research models.
Read More
Primary biliary cholangitis therapeutics market to reach $1.85 billion by 2030 at 12.9% cagr, driven by increasing prevalence of liver diseases associated with alcohol consumption.
Read More
Pre-workout vegan supplements market to reach $10.43 billion by 2030 at 13.1% cagr, driven by rising demand for plant-based products among health-conscious consumers.
Read More
Preventive vaccines market to reach $131.27 billion by 2030 at 9.8% cagr, driven by increasing prevalence of infectious diseases and rising focus on preventive healthcare.
Read More
Prescription pain medication market to reach $100.16 billion by 2030 at 5.3% cagr, driven by increasing prevalence of arthritis and chronic joint inflammation.
Read More
Prescription orthopedic drugs market to reach $67.5 billion by 2030 at 5.7% cagr, driven by increasing incidence of musculoskeletal disorders caused by aging and lifestyle factors.
Read More
Prescription drugs market to reach $2368.39 billion by 2030 at 10.5% cagr, driven by increasing drug production to meet growing global healthcare demand.
Read More
Prescription dermatological drugs market to reach $54.27 billion by 2030 at 6.3% cagr, driven by increasing prevalence of dermatological conditions linked to urbanization and lifestyle changes.
Read More